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Melanoma growth-stimulatory activity (MGSA), referringto apeptide of73 amino
acids, was reported to be mitogenic forcultured human melanoma cells (1, 2). Ma-
ture MGSA has marked sequence similarity to several recently discovered inflam-
matory peptides, ofwhich, thehumanneutrophil-activatingpeptide 1 (NAP-1/IL-8)
was studied most extensively thus far (3, 4). In addition to monocytes, NAP-1/IL-8
was found to be produced by awide variety oftissue cells, including fibroblasts and
endothelial cells, upon stimulation with IL-1 and TNF (3). It induces neutrophil
shape changes, chemotaxis, exocytosis ofspecific and azurophilic granules and the
respiratory burst (3) in vitro, and causes exudation and massive neutrophil infiltra-
tion in vivo (5). In view ofthe structural similarities to NAP-1/IL-8 (Fig. 1), it was
ofparticular interest to test MGSA for neutrophil-activating and chemotactic prop-
erties. This report shows that MGSA, prepared by chemical synthesis, is a potent
inflammatory agonist acting on neutrophils both in vitro as well as in vivo.
Materials.
￿
Fura-2/AM and BSA were purchased from Fluka AG, Buchs, Switzerland.
HumanrecombinantNAP-1/IL-8 wasobtained from the Sandoz Research Institute, Vienna,
Austria (6). The sources of other special reagents were described previously (7).
Synthesis ofMGSA.
￿
MGSA was synthesized by stepwise solid-phase methods on a peptide
synthesizer (430A; AppliedBiosystems, Inc., Foster City, CA)usingdouble-couple protocols
fortBoc amino acids, as describedpreviously (8). Afterdeprotection, purification,andfolding
(9), homogeneity of the material was analyzed by reverse-phase HPLC and IEF (Fig. 2).
Amino acid analysis gave the composition expected, and theM,. of 7,857 daltons, deduced
by mass spectroscopy, was consistent with the calculated value of 7,859 daltons for MGSA.
Cell Preparation.
￿
Human neutrophils were isolated from buffy coats of donor blood (7).
The final suspension consisting of 10' cells/ml in 0.15 M NaCl supplemented with 0.05 mM
CaC12 was kept at 10°C until use.
Biological Assays.
￿
Elastase release (7, 10), H202 production (11), neutrophil chemotaxis
(12), and cytosolic-free calciumchanges(13) were determined accordingto established methods.
In Vivo Activity.
￿
Adult male Wistar rats were given intradermal injections of NAP-1/IL-8
or MGSA (10-9, 10-'°, 10-", or 10-12 mol/site) in 0.05 ml pyrogen-free saline. Full-thickness
skin samples were fixed in 4% formalin, embedded in paraffin, stained with hematoxylin
and eosin, and examined by light microscopy (5).
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FIGURE 1 .
￿
Structural similarities between MGSA and NAP-1/IL-8 . The proteins were aligned
according to their four cysteine residues (arrow heads) . Conserved amino acids are boxed .
Results
Activation ofHuman Neutrophils.
￿
The effect of MGSA in inducing exocytosis as
assessed by the release ofelastase from azurophil granules wasconcentration depen-
dent and similar to that of NAP-1/IL-8 (Fig. 3 a) . Both peptides were effective in
the same molar range and elicited a response at the threshold concentration of 3 x
10 -10M . NAP-1/IL-8 was somewhat more potent (25-35%) than MGSA through-
out the range of concentrations tested . NAP-1/1L-8 also induced a rapid and tran-
sient respiratory burst response at concentrations of 10-9 to 10 -7 M, confirming
former results (6) . By contrast, MGSA showed only borderline activity (Fig . 3 b) .
At 10' M, the highest concentration tested, MGSA-stimulated neutrophils pro-
duced <2% (<10 pmol) of the H202 obtained with NAP-1/IL-8 .
The data summarized in Table I demonstrate that MGSA is chemotactic as well .
Both MGSA and NAP-1/1L-8 induced neutrophil migration in the concentration
range of 10 -1° to 10' M, with maximal effects at 10 -8M. As seen in exocytosis,
MGSA was slightly less potent as a chemoattractant than NAP-1/IL-8 .
Like classical chemotactic agonists, such as C5a and fet-Leu-Phe, MGSA in-
duced a transient rise in the concentration of cytosolic-free calcium ([Ca21],) . Cal-
cium mobilization was observed at concentrations as low as 10 -1° M, and a max-
imal transient elevation was reached at 10 8M (Fig. 4, inset) . The curves in Fig .
4, representing the maximal rates in raising [Ca"] ;as a function ofMGSA or NAP-
1/IL-8 concentration, were virtually identical . The rates in mobilizing cytosolic-free
calcium did not reach a plateau in the range of concentrations tested .
In Vivo Effects ofMGSA .
￿
Light microscopy of skin samples taken 4 h after in-
FIGURE 2 .
￿
Analysis ofpurified syntheticMGSA . 15 wl of
the purified peptide(1 mg/ml) was loaded onto aVydac C-18
reverse-phase HPLC column and eluted with a 0-60%
water-acetonitrile gradient . The inset represents a silver-
stainedIEF gel ofpurifiedMGSA. The gel was equilibrated
in 8Murea, 2% AmpholinespH 8-11, then runand stained
using the"PHAST" electrophoresis system (Pharmacia Fine
Chemicals, Piscataway, NJ) . The pH gradient was deter-
mined using a surface pH electrode and positions corre-
sponding to pH 8.0 and 11.0 are indicated . The pl ofMGSA
was estimated to be 9.6 (arrow head) .200
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FIGURE 3 .
￿
(a) Release of elastase from cytochalasin B-treated human neutrophils stimulated
with MGSA (" ) or NAP-1/IL-8 (O). Elastase activity is expressed in relative fluorescence units
(1 U = 1 pMol 7-amino-4-methylcoumarine produced/min/106 cell) (10) . (b) Production of H202
by neutrophils after stimulation with MGSA or NAP-1/IL-8 . The rate of H202 production is
proportional to the chemiluminescence intensity (volts) (11). In the experiment shown, the max-
imal rate of H202 production with 10-7M NAP-1/IL-8 was -50 FMol/s/10 6 cells . NAP-1/IL-8
(t%) and MGSA (bottom) were tested at 10-7 , 10-s , 10-9 , and 10 - " M (top to bottom) . Similar
values were obtained in two (a) and one (b) additional experiments performed with different cell
preparations .
tradermal application ofMGSA at 10-9 mol/site demonstrated a massive infiltra-
tion ofneutrophils (Fig. 5) . No other granulocytes, monocytes, or lymphocytes were
detected . The infiltration was most prominent around venules in the deeper dermal
layers (Fig . 5 a), but extended downwards into the subcutis and upwards into the
upper dermis . Significant responses of decreasing intensities were obtained with
10- '°, 10 - ", and 10 - ' 2 mol/site (data not shown) .
Discussion
This study shows that synthetic MGSA activates and is chemotactic for human
neutrophils in vitro and induces massive neutrophil infiltration in vivo . Except for
the respiratory burst response, its potency is similar to that of NAP-1/IL-8 .
TABLE I
Neutrophil Chemotaxis Induced by MGSA and NAP-111L-8
Numbers refer to chemotactic indices (mean t SD ; n = 3) . 2 x 10 5 cells/
Boyden chamber were used (12) ; random migration in the absence of stimuli
amounted to 3 .63 t 0.44 x 104 cells .
Stimuli
nm
NAP-1/IL-8 MGSA
0 .1 1 .67 t 0.18 1 .30 t 0.13
1 .0 2 .02 t 0.08 1 .72 t 0.10
10 2 .07 t 0.09 1 .83 t 0.12
100 1 .85 t 0.29 1 .76 t 0.131800
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FIGURE 4 . Rate of cytosolic calcium rise in
human neutrophils stimulated with MGSA (")
andNAP-1/IL-8 (O) . Values represent themean
oftwo separate experiments. The inset shows the
transient changes in [Ca2.]; expressed in percent
Fura-2 saturation after stimulation with MGSA .
Resting and maximal level of [Ca2'I ; were esti-
mated to be 0.1 and 0.6 pM, respectively (13) .
The curves, from top to bottom, correspond to
10-x, 10-s, 10-9 , and 10-0MMGSA . Addition
of the stimulus at time zero is indicated by the
arrow.
MGSA and NAP-1/IL-8 were prepared by unrelated methods, stepwise chemical
synthesis for the former, and expression in Eschenchta colt ofa synthetic gene for the
latter(6) . Chemical synthesis hasestablished itselfas an alternative approach to recom-
binant technologies for the production of biologically active polypeptides of consid-
erable size, such as IL-3 (8, 9) and thehuman granulocyte-macrophage CSF (14) .
TheMGSA preparation was found to be ofhigh purity, and it thus appears unlikely
that the effects reported here are due to synthetic byproducts .
The in vitro and in vivo effects reported in this study indicate that MGSA may
function as an inflammatory mediator by mechanisms similar to those postulated
for NAP-1/1L-8 (3) . Recent findings showing that the gene coding for MGSA
(gro/MGSA) is expressed in several types of tissue cells supports this hypothesis .
FIGURE 5 .
￿
Histology of rat lower dermis 4 h after intradermal injections of 10-9 mol MGSA .
Skin samples were processed as described in Materialsand Methods . (a) MGSA ; (b) saline con-
trol . Solid bar represents 100 pm .MOSER ET AL.
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Anisowicz et al. (15) demonstrated by Northern blot analysis that the gro/MGSA
mRNA levels are considerably elevated in human fibroblasts and mammary epithe-
lial cells exposed to inflammatory stimuli such as IL-1 or phorbol 12-myristate 13-
acetate. In addition, Wen et al. (16) reported the induction ofgro/MGSA expression
in human endothelial cells after stimulation with TNF, IL-1, or LPS.
Richmond et al. (1) identified MGSA on the basis of its mitogenic activity for
Hs294T human melanoma cells. Biochemical and immunocytochemical studies on
human melanoma biopsies suggested that MGSA is involved in maintenance of tumor
progression. The present study demonstrating the potent neutrophil-activating prop-
erties of MGSA indicates that this peptide, in addition to its reported mitogenic
activity, may function as a mediator of inflammation.
Summary
Melanoma growth-stimulatory activity (MGSA), a peptide reported to be mito-
genic for Hs294T human melanoma cells, has extensive sequence similarity to the
neutrophil-activating peptide NAP-1/IL-8, suggesting functional similarities. To test
this hypothesis, MGSA was chemically synthesized and tested for its effects on human
neutrophils. It was found to induce chemotaxis, exocytosis of elastase, and changes
in cytosolic-free calcium to an extent and at concentrations similar to NAP-1/IL-8.
However, MGSA was considerably less potent than NAP-1/IL-8in inducing the respir-
atory burst. Intradermal injections in rats of MGSA resulted in a massive accumu-
lation of neutrophils. Our data demonstrate that, apart from its growth-stimulatory
activity, MGSA is a potent inflammatory agonist with neutrophil-stimulating prop-
erties.
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